01-10-2026 16:53 via medpagetoday.com

'Lean' MASLD May Sound Better, but Study Suggests Otherwise

(MedPage Today) -- While patients with lean metabolic dysfunction-associated steatotic liver disease (MASLD) have less severe histologic disease, they still had a similar risk of adverse clinical outcomes as those with overweight/obese MASLD, according...
Read more »

Medical Industry news



FDA Approves Only Surgical Pulmonary Valve Fit for Growing Kids
Striking Weight Loss Seen With Combo Drug in Diabetes Trial
GLP-1s Tied to Detached Fingernails in New Study
Docs Condemn 'Cornell 7'; Patient Zero vs Primary Case; Top 10 Natural Laxatives
Doctors Push Back on RFK Jr.'s AI Comments
Assessing Pathology and How It Impacts Early HER2 Breast Cancer Treatment
Novel GIP/GLP-1 Yields Uneven Findings in Diabetes Patients With Obesity
New Gastro Guidelines; Best First-Line Option in UC? Late-Stage Trial Win for Hep D
More New Moms Are Starting GLP-1 Drugs
Cemdisiran Linked With Fewer Hospitalizations in Myasthenia Gravis Study
Drug Approval for Painful Heart Condition Expands to Kids
What Is a 'Tick Bomb' and Does It Cause Disease?
Efgartigimod Shows Sustained Efficacy in Myasthenia Gravis Subtypes
Nurse Choked With Stethoscope; $15M Award for Blinded Patient; Fake Ozempic Charges
Desktop versie